Lenacapavir Sodium CAS 2283356-12-5

1.DETAILS
Lenacapavir sodium CAS 2283356-12-5, A long-acting HIV capsid inhibitor with a novel mechanism of action.
Mechanism of action ：Interfere with viral capsid synthesis through multiple pathways to reduce viral assembly and release
Core Strengths ：
1、High efficacy: In Phase III trials, the HIV prevention efficacy reached 100% among female populations and 96% among male and gender-diverse populations, with a high level of evidence certainty.
2、Long half-life: Only 2 injections per year.
3、Broad-spectrum activity with no cross-resistance to existing ART drugs.